Crossmark Global Holdings’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,070
| Closed | -$62K | – | 1390 |
|
|
2019
Q2 | $62K | Buy |
+10,070
| New | +$62K | ﹤0.01% | 1378 |
|
|
2018
Q4 | – | Sell |
-14,740
| Closed | -$92K | – | 1603 |
|
|
2018
Q3 | $92K | Buy |
14,740
+130
| +0.9% | +$811 | ﹤0.01% | 1578 |
|
|
2018
Q2 | $117K | Sell |
14,610
-110
| -0.7% | -$881 | ﹤0.01% | 1569 |
|
|
2018
Q1 | $110K | Sell |
14,720
-1,890
| -11% | -$14.1K | ﹤0.01% | 1554 |
|
|
2017
Q4 | $99K | Sell |
16,610
-24,870
| -60% | -$148K | ﹤0.01% | 1633 |
|
|
2017
Q3 | $305K | Buy |
+41,480
| New | +$305K | 0.01% | 1306 |
|
|
2016
Q3 | $305K | Buy |
+41,480
| New | +$305K | 0.01% | 1306 |
|